Recurrent spontaneous abortions-An update on diagnosis and management

Journal fur Reproduktionsmedizin und Endokrinologie

Volumn 6, Issue 1, 2009, Pages 11-16

  Von Pildner Steinburg, S ^a   Schneider, K T M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Etiology; Genetic counseling; Management; Recurrent spontaneous abortions; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; BROMOCRIPTINE; DALTEPARIN; ENOXAPARIN; FOLIC ACID; FOLLITROPIN; HEPARIN; IMMUNOGLOBULIN; LUPUS ANTICOAGULANT; LUTEINIZING HORMONE; METFORMIN; PHOSPHOLIPID ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDNISONE; PROGESTERONE; PROTEIN C; PROTEIN S; THYROTROPIN;

ANTIPHOSPHOLIPID SYNDROME; CASE MANAGEMENT; ENDOCRINE DISEASE; GENETIC COUNSELING; GESTATIONAL AGE; HUMAN; HYPERPROLACTINEMIA; METRITIS; OVARY POLYCYSTIC DISEASE; PATIENT COUNSELING; PSYCHOTHERAPY; RECURRENT ABORTION; REVIEW; RISK FACTOR; SCREENING; SPONTANEOUS ABORTION; THROMBOPHILIA; TRISOMY; UTERUS MALFORMATION;

EID: 62449302482     PISSN: 18102107     EISSN: 18109292     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Marzusch M, Pildner von Steinburg S. Fruhschwanger-schaft:Klinische Aspekte. In:Schneider H, Husslein P, Schneider KTM (Hrsg). Die Geburtshilfe. 3. Aufl. Springer Medizin Verlag, Heidelberg, 2006;18-9.
2. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, Armstrong EG, Nisula BC. Incidence of early loss of pregnancy. N Engl J Med 1988;319:189-94.
3. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss:population based register linkage study. Br Med J 2000;320:1708-12.
4. Rai R, Regan L. Recurrent miscarriage. Lancet 2006;368:601-11.
5. Stirrat GM. Recurrent miscarriage. Lancet 1990;336:673-5.
6. Hogge WA, Byrnes AL, Lanasa MC, Surti U. The clinical use of karyotyping spontaneous abortions. Am J Obstet Gynecol 2003;189:397-400.
7. Warren JE, Silver RM. Genetics of pregnancy loss. Clin Obstet Gynecol 2008;51:84-95.
8. Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update 2001;7:161-74.
9. Li TC, Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage:aetiology, management and prognosis. Hum Reprod Update 2002;8:463-81.
10. Yu D, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndrome-one century later. Fertil Steril 2008;89:759-79.
11. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2007 (1):CD000262.
12. Artmann A, Schuchardt R, Gnirs J, Schelling M, Schneider KTM. Der totale Muttermundverschluss-eine effiziente Maßnahme bei prolabierender Fruchtblase im Bereich der extremen Frühgeburtlichkeit? Zeitschr Gebh Neonat 2001;4:143-6.
13. Odoj A, Schneider KTM, Pildner von Steinburg S. Verschluss-operationen am Muttermund-eine retrospektive Auswertung über 11 Jahre. Geburtsh Frauenheilk 2008;68 (Suppl 1):S92;DOI:10.1055/s-0028-1088944. Abstract.
14. Rosenn B, Miodovnik M, Combs CA, Khoury J, Siddiqi TA. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 1994;84:515-20.
15. Prummel MF, Wiersinga WM. Thyroid autoimmunity and miscarriage. Eur J Endocrinol 2004;150:751-5.
16. Hirahara F, Andoh N, Sawai K, Hirabuki T, Uemura T, Minaguchi H. Hyperprolactinemic recurrent miscarriage and results of randomised bromocriptine treatment trials. Fertil Steril 1998;70:246-52.
17. Cocksedge KA, Li TC, Saravelos SH, Metwally M. A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage. Reprod Biomed Online 2008;17:151-60.
18. Wieacker P, Hehr U, Gromoll J, Ludwig M. Empfehlungen zur genetischen Diagnostik bei Aborten. [Recommendations for Genetic Diagnostics in Abortions.] J Reproduktionsmed Endokrinol 2005;2:148-50.
19. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002;2:656-63.
20. Shimada S, Kato EH, Morikawa M, Iwabuchi K, Nishida R, Kishi R, Onoé K, Minakami H, Yamada H. No difference in natural killer or natural killer T-cell population, but aberrant T-helper cell population in the endometrium of women with repeated miscarriage. Hum Reprod 2004;19:1018-24.
21. Hutton B, Sharma R, Fergusson D, Tinmouth A, Hebert P, Jamieson J, Walker M. Use of intravenous immunoglobulin for treatment of recurrent miscarriage:a systematic review. Br J Obstet Gynaecol 2007;114:134-42.
22. Empson M, Lassere M, Craig JC, Scott JR. Recurrent pregnancy loss with antiphospholipid antibody:a systematic review of therapeutic trials. Obstet Gynecol 2002;99:135-44.
23. Schleussner E, Thaler CJ, Fischer T, Bauersachs R. Dalteparin und ASS 100 zur Therapie des Antiphospholipid-Syndroms (APS):Ergebnisse der ETHiG I Studie. Geburtsh Frauenheilk 2008;68 (Suppl 1);DOI:10.1055/s-0028-1088653. Abstract.
24. Middeldorp S. Thrombophilia and pregnancy complications:cause or association? J Thromb Haemost 2007;5 (Suppl 1):276-82.
25. Bogdanova N, Markoff A. Genetic Predispositions to Throm-bophilia Associated with Recurrent Pregnancy Loss. J Reproduktionsmed Endokrinol 2008;5:101-5.
26. Kluijtmans LA, den Heijer M, Reitsma PH, Heil SG, Blom HJ, Rosendaal FR. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis. Thromb Haemost 1998;79:254-8.
27. Jood K, Ladenvall P, Tjärnlund-Wolf A, Ladenvall C, Andersson M, Nilsson S, Blomstrand C, Jern C. Fibrinolytic gene polymorphism and ischemic stroke. Stroke 2005;36:2077-81.
28. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss:a meta-analysis. Lancet 2003;361:901-8.
29. Sotiriadis A, Makrigiannakis A, Stefos T, Paraskevaidis E, Kalantaridou SN. Fibrinolytic defects and recurrent miscarriage:a systematic review and meta-analysis. Obstet Gynecol 2007;109:1146-55.
30. Hanson NQ, Aras O, Yang F, Tsai MY. C677T and A1298C polymorphisms of the methylentetrahydrofolate reductase gene:incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem 2001;47:661-6.
31. Goodman CS, Coulam CB, Jeyendran RS, Acosta VA, Roussev R. Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immun 2006;56:230-6.
32. Subrt I, Ulvova-Gallova Z, Bibkova K, Micanova Z, Hejnalova M, Cerna M, Hradecky L, Novotny Z. Recurrent pregnancy loss and frequency of eight antiphospholipid antibodies and genetic thrombophilic factors in Czech women. Am J Reprod Immun 2008;59:193-200.
33. Buchholz T, Lohse P, Rogenhofer N, Kosian E, Pihusch R, Thaler CJ. Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages. Hum Reprod 2003;18:2473-7.
34. Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Database Syst Rev 2008 (2):CD003511.
35. Gris JC, Mercier E, QuéréI, Lavigne-Lissalde G, Cochery-Nouvellon E, Hoffet M, Ripart-Neveu S, Tailland ML, Dauzat M, Mares P. Low-molecular-weight heparin vs. low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004;103:3695-9.
36. Dendrinos S, Kalogirou I, Makrakis E, Theodoridis T, Mahmound EA, Christopoulou-Cokkinou V, Creatsas G. Safety and effectiveness of tinzaparin sodium in the management of recurrent pregnancy loss. Clin Exp Obstet Gynecol 2007;34:143-5.
37. Ogasawara MS, linuma Y, Aoki K, Katano K, Ozaki Y, Suzumori K. Low-dose aspirin is effective for treatment of recurrent miscarriage in patients with decreased coagulation factor XII. Fertil Steril 2001;76:203-4.
38. Carp H, Dolitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost 2003;1:433-8.
39. Bauersachs RM, Dudenhausen J, Faridi A, Fischer T, Fung S, Geisen U, Harenberg J, Herchenhan E, Keller F, Kemkes-Matthes B, Schinzel H, Spannagl M, Thaler CJ. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost 2007;98:1237-45.
40. Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss:the LIVE-ENOX study. J Thromb Haemost 2005;3:227-9.
41. Deutsche Gesellschaft fir Gynakologie und Geburtshilfe. Leitlinien, Empfehlungen, Stellungnahmen. Diagnostik und Therapie beim wiederholten Spontanabort. AWMF 015/050 (S1), 2008.
42. Tzafettas J, Petropoulos P, Psarra A, Delkos D, Papaloukas C, Giannoulis H, Kalogiros G, Gkoutzioulis F. Early antiplatelet and antithrombotic therapy in patients with a history of recurrent miscarriages of known and unknown aetiology. Eur J Obstet Gynecol Reprod Biol 2005;120:22-6.
43. Badawy AM, Khiary M, Sherif LS, Hassan M, Ragab A, Abdelall I. Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. J Obstet Gynaecol 2008;28:280-4.
44. Fawzy M, Shokeir T, El-Tatongy M, Warda O, El-Refaiey AA, Mosbah A. Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage:a randomized placebo-controlled study. Arch Gynecol Obstet 2008;278:33-8.
45. The ETHiG II trial group;http://www.ethig2.de (letzter Zugriff:02.02.2009)
46. Stray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984;148:140-6.